Develops synthetic regenerative biomaterials for womens health, notably breast tissue reconstruction.
| Date | Round | Amount |
|---|---|---|
| Dec 2023 | Pre Seed Eindhoven-based VivArt-X raised EUR660K in a pre-seed round to advance its biodegradable biomaterial for tissue regeneration. | $710K |